Arman Financial's consolidated PAT turns ₹45 Cr in Q1FY27 vs year-ago loss; NPM 22.4%
revenue +33.63% · margins expanding
₹201.78 Cr
+33.63% YoY
₹45.17 Cr
22.38%
+32pp YoY
₹42.96
Arman Financial Services posted consolidated PAT of ₹45.17 Cr in Q1 FY27 against a ₹14.58 Cr loss in Q1 FY26 — a clear YoY turnaround, with net profit margin swinging from -9.66% to +22.38%. Consolidated total income rose 33.6% YoY (and 14.9% QoQ) to ₹201.82 Cr. Sequentially, PAT growth moderated to 10.1% over Q4FY26's ₹41.01 Cr, and NPM eased slightly from 23.36% to 22.38%, so the YoY swing — not the QoQ print — is the real story this quarter.
Q1 FY-2027 vs prior quarters
The bridge on the YoY move shows credit costs, not just growth, did the heavy lifting: impairment losses on financial assets fell to ₹19.50 Cr from ₹66.52 Cr in Q1FY26, a ₹47.02 Cr reduction that accounts for roughly two-thirds of the ₹68.34 Cr swing in pre-tax profit (from -₹11.17 Cr to +₹57.17 Cr). Revenue growth added a further ₹50.81 Cr, but this was partly offset by higher finance cost (+₹12.06 Cr YoY, +21.8% QoQ to ₹64.28 Cr on a more debt-funded book, consolidated debt-equity 2.01x), employee cost (+₹9.15 Cr) and other opex (+₹8.25 Cr) — which is also why NPM softened slightly quarter-on-quarter even as the topline kept growing.
The stock went into the print at ₹2,006.6, up 2.5% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 3 consecutive quarters; revenue is at a 6-quarter high.
Management expects continued momentum in disbursements, with a strong emphasis on responsible and disciplined growth within defined risk parameters, prioritizing portfolio quality over aggressive expansion. Key priorities for FY27 include maintaining collection efficiencies, monitoring asset quality, investing in credi
We found no credible independent street estimate for this print — the only online figure located (an automated blog projecting revenue down 17.9% YoY and a wider loss) was wildly inconsistent with the filed numbers and has been discarded rather than used. Management's own prior guidance (from the Q4FY26 concall) targeted ROA of 3.5-4%+ and cost-to-assets falling to ~7% from ~9% in FY26; neither is directly verifiable from this statement, which doesn't disclose average assets. Asset quality held steady: consolidated gross Stage III assets are 2.76% (net 0.84%), standalone 3.14% (net 0.71%, CRAR 33.57%), with no NPA transfers or stressed-loan acquisitions this quarter. Subsidiary Namra Finance (the MFI arm) contributed ~₹29.62 Cr of the ₹45.17 Cr consolidated PAT, versus parent-standalone PAT of ₹14.59 Cr — underscoring how central the microfinance book now is to group profitability. The same board meeting also granted 3,600 ESOPs at a ₹500 exercise price and confirmed Pushpendrakumar as permanent Head–Internal Audit; neither is financially material to the quarter. No management press release/commentary was available in this filing — that context is pending the August 13, 2026 earnings call.
W1
Finance cost rose 21.8% QoQ to ₹64.28 Cr (consolidated, debt-equity 2.01x) — watch whether NPM (22.38% this quarter) stabilizes as the book keeps scaling.
W2
Impairment/credit costs fell to ₹19.50 Cr from ₹66.52 Cr YoY, driving most of the PBT swing — watch whether Stage III assets (2.76% gross / 0.84% net, consolidated) hold or normalize higher.
W3
Management's FY27 targets from the Q4FY26 concall (ROA 3.5-4%+, cost-to-assets down to ~7% from ~9%) aren't verifiable from this filing — watch the August 13, 2026 earnings call for an update.
Converted from ₹ Lakhs; no exceptional items in either statement; Q4FY26 comparative is a balancing figure per Note 6, not a discrete audited quarter; consolidated PAT includes wholly-owned subsidiary Namra Finance, which contributed ~₹29.62 Cr of group PAT per the auditor's other-matters note.